FDA Finally Approves Long-Awaited Major Depressive Drug
The FDA has finally approved a tablet developed by Fabre-Kramer Pharmaceuticals for adults with major depressive disorder, after a 24-year-long process involving multiple companies and regulatory scrutiny over its efficacy. The drug, known as Exxua (gepirone), is expected to be available in pharmacies in early 2024.